Brett Giroir

https://en.wikipedia.org/wiki/Brett_Giroir

Brett P. Giroir (born November 4, 1960) is an American pediatrician and a former four-star admiral in the U.S. Public Health Service Commissioned Corps. Dr. Giroir currently serves as CEO and a member of the Board of Directors for Altesa BioSciences, Inc, a clinical stage biopharmaceutical company focusing on developing new treatments for respiratory viruses and global viral threats. He is also a co-founder and independent director for Revelar Biotherapeutics, and an independent director for OncoNano Medicine. His non-profit activities include Board service on the Global Virus Network[7] and Remote Area Medical (RAM), and he remains active in global humanitarian initiatives in Latin America and Sub-Saharan Africa. He previously served as the 16th assistant secretary for health during the Trump administration from February 15, 2018, to January 19, 2021. He concurrently served as the secretary's principal public health and science adviser, the senior adviser for the Health Resources and Services Administration, the Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration as well as the senior adviser to the secretary for Opioid Policy. From 2020 to 2021, he served additionally as the director of the U.S. coronavirus diagnostic testing, and as the U.S. representative on the World Health Organization Executive Board. As COVID-19 testing czar, he was part of the White House Coronavirus Task Force.

From 2004 to 2008, Giroir served as the deputy director, and then a director, of DARPA's Defense Science Office, vice chancellor for the Texas A&M University System from 2008 to 2013, and as the chief executive officer of the Texas A&M Health Science Center from 2013 to 2015.[13]

Giroir starting in 2016 served as president and CEO of ViraCyte, LLC, a clinical-stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe infections. He also served as a senior fellow at the Texas Medical Center Health Policy Institute and strategic advisor for the Texas Medical Center Innovation Institute (TMCII). He was a member of the Texas Task Force for Infectious Disease Preparedness and Response, and adjunct professor of pediatrics at the Baylor College of Medicine in Houston.[14]

Giroir served as the Acting Commissioner of Food and Drugs in November and December 2019, while Stephen Hahn's nomination was pending in the Senate.